Previous close | 2,294.50 |
Open | 2,291.50 |
Bid | 2,269.00 x 0 |
Ask | 2,271.50 x 0 |
Day's range | 2,269.00 - 2,300.00 |
52-week range | 2,238.00 - 2,966.50 |
Volume | |
Avg. volume | 2,164,839 |
Market cap | 1.066T |
Beta (5Y monthly) | 0.18 |
PE ratio (TTM) | 8.60 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 80.00 (3.49%) |
Ex-dividend date | 28 Mar 2024 |
1y target est | N/A |
Q4 2023 Cue Biopharma Inc Earnings Call
Advancements in Clinical Trials and Strong Cash Position Highlighted
Ono Pharmaceutical Co. (OPHLF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.